Trials / Terminated
TerminatedNCT00208455
A Multi-centre Study to Assess the Long-term Performance of the DePuy PROXIMA™ Hip in Primary Total Hip Replacement
An Uncontrolled, Multi-Centre, Prospective, Post Marketing Surveillance Study to Monitor the Long Term Survivorship of the DePuy PROXIMA™ Hip in Subjects Requiring a Total Hip Replacement
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 184 (actual)
- Sponsor
- DePuy International · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to monitor the performance of the DePuy PROXIMA™ hip in the treatment of patients with hip joint disease requiring a total hip replacement. Patients who enter the study will be evaluated at regular intervals following hip surgery using patient, clinical and x-ray assessments. A subset of patients will undergo scans to allow the bone mineral density of the bone surrounding the implant to be monitored
Conditions
- Rheumatoid Arthritis
- Osteoarthritis
- Post-traumatic Arthritis
- Avascular Necrosis
- Traumatic Femoral Fractures
- Congenital Hip Dysplasia
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DePuy Proxima™ Hip | A short, anatomic, cementless femoral component for use in total hip arthroplasty |
Timeline
- Start date
- 2005-02-01
- Primary completion
- 2012-09-01
- Completion
- 2013-02-01
- First posted
- 2005-09-21
- Last updated
- 2017-06-26
Locations
4 sites across 4 countries: Germany, Italy, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT00208455. Inclusion in this directory is not an endorsement.